CAR Density Influences Antitumoral Efficacy of BCMA CAR T cells

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma

Chimeric antigen receptor T cells immunotherapy: challenges and opportunities in hematological malignancies

Engineering-enhanced CAR T cells for improved cancer therapy

Frontiers Strategies for enhancing CAR T cell expansion and persistence in HIV infection

CAR Density Influences Antitumoral Efficacy of BCMA CAR T cells and Correlates with Clinical Outcome

Frontiers Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management Strategies

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome

Full article: Dissecting factors influencing response to CAR T cell therapy in B lymphoid hematologic malignancies: from basic to practice

State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation

CTLA-4 tail fusion enhances CAR-T anti-tumor immunity

Scientists identify a biomarker that predicts

Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell Leukemia: Molecular Therapy

IJMS, Free Full-Text

Engineering strategies to overcome the current roadblocks in CAR T cell therapy